Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: early results
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: early results ; volume:8 ; number:1 ; day:9 ; month:4 ; year:2013 ; pages:1-7 ; date:12.2013
Radiation oncology ; 8, Heft 1 (9.4.2013), 1-7, 12.2013
- Urheber
-
Aluwini, Shafak
- Beteiligte Personen und Organisationen
-
van Rooij, Peter
Hoogeman, Mischa
Kirkels, Wim
Kolkman-Deurloo, Inger-Karine
Bangma, Chris
SpringerLink (Online service)
- DOI
-
10.1186/1748-717X-8-84
- URN
-
urn:nbn:de:1111-201604097857
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:04 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Aluwini, Shafak
- van Rooij, Peter
- Hoogeman, Mischa
- Kirkels, Wim
- Kolkman-Deurloo, Inger-Karine
- Bangma, Chris
- SpringerLink (Online service)
Ähnliche Objekte (12)
Focal radiotherapy boost to MR-visible tumor for prostate cancer: a systematic review
Lacosamide as monotherapy in focal seizure: Literature review
Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial
Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible
Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm
Prostate stereotactic body radiotherapy with simultaneous integrated boost: which is the best planning method?
PROstate Multicentre External beam radioTHErapy Using a Stereotactic boost: the PROMETHEUS study protocol
Feasibility of a simultaneously integrated boost concept for hypofractionated stereotactic radiotherapy of unresected brain metastases
Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancer
Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancer
Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment
Focal radiotherapy boost to MR-visible tumor for prostate cancer: a systematic review
Lacosamide as monotherapy in focal seizure: Literature review
Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial
Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible
Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm
Prostate stereotactic body radiotherapy with simultaneous integrated boost: which is the best planning method?
PROstate Multicentre External beam radioTHErapy Using a Stereotactic boost: the PROMETHEUS study protocol
Feasibility of a simultaneously integrated boost concept for hypofractionated stereotactic radiotherapy of unresected brain metastases
Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancer
Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancer
Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment
Focal radiotherapy boost to MR-visible tumor for prostate cancer: a systematic review
Lacosamide as monotherapy in focal seizure: Literature review
Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial
Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible
Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm
Prostate stereotactic body radiotherapy with simultaneous integrated boost: which is the best planning method?
PROstate Multicentre External beam radioTHErapy Using a Stereotactic boost: the PROMETHEUS study protocol
Feasibility of a simultaneously integrated boost concept for hypofractionated stereotactic radiotherapy of unresected brain metastases
Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancer
Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancer